Spectranano Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-01-2025
- Paid Up Capital ₹ 1.00 M
as on 07-01-2025
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Revenue -42.36%
(FY 2020)
- Profit 34.25%
(FY 2020)
- Ebitda 40.69%
(FY 2020)
- Net Worth -43.42%
(FY 2020)
- Total Assets -28.44%
(FY 2020)
About Spectranano Laboratories
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Karthik Veerabadran, Uma Rani, Sharada Chaturvedi, and Three other members serve as directors at the Company.
- CIN/LLPIN
U36999TN2017PTC115401
- Company No.
115401
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Mar 2017
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Spectranano Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karthik Veerabadran  | Managing Director | 09-Mar-2017 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Uma Rani | Whole-Time Director | 09-Mar-2017 | Current |
| Sharada Chaturvedi | Director | 16-Mar-2018 | Current |
| Chetan Sharma | Additional Director | 07-May-2024 | Current |
| Karthik Vithikaa | Additional Director | 07-May-2024 | Current |
| Abhishek Sharma | Director | 16-Mar-2018 | Current |
Financial Performance of Spectranano Laboratories.
Spectranano Laboratories Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 42.36% decrease. The company also saw a substantial improvement in profitability, with a 34.25% increase in profit. The company's net worth observed a substantial decline by a decrease of 43.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spectranano Laboratories?
Unlock access to Spectranano Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Spectranano Laboratories?
Unlock and access historical data on people associated with Spectranano Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spectranano Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spectranano Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
